Controlled Crystallization of Active Pharmaceutical Ingredients
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: closed (15 April 2021) | Viewed by 16140
Special Issue Editor
Interests: biomineralization; pharmaceutical crystallization; interfacial phenomena
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Crystallization is an important separation process that generates crystalline materials with high purity and yield. In the area of pharmaceutical research, crystallization of active pharmaceutical ingredients (APIs) has been vigorously studied because of its great influence on the physicochemical properties of APIs. Size, shape, and phase of the crystals are some of the features frequently controlled during crystallization and they are closely related to the solubility, dissolution rate, and stability of the resulting API solid forms.
The aim of this Special Issue is to provide a forum for researchers in the broad field of pharmaceutical crystallization. While the focus is specifically on the crystallization of APIs, this Special Issue is open to original research and review articles on all aspects of pharmaceutical crystallization.
Prof. Il Won Kim
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Active pharmaceutical ingredients
- Crystal shape and size (e.g., nanodrug)
- Crystal phases (e.g., polymorph, salt, cocrystal)
- Separation processes (e.g., purity, chirality)
- Industrial process development
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.